Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role

Alford, 1994, A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain, J Histochem Cytochem, 42, 283, 10.1177/42.2.8288869 Alvarez, 2001, A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons, Exp Cell Res, 264, 266, 10.1006/excr.2001.5152 Avila, 2002, Tau function and dysfunction in neurons: its role in neurodegenerative disorders, Mol Neurobiol, 25, 213, 10.1385/MN:25:3:213 Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol (Berl.), 82, 239, 10.1007/BF00308809 Chen, 2001, Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation, Am J Pathol, 159, 1597, 10.1016/S0002-9440(10)63005-2 Dhar, 1991, Involvement of pp60c-src in platelet-activating factor-stimulated platelets. Evidence for translocation from cytosol to membrane, J Biol Chem, 266, 18797, 10.1016/S0021-9258(18)55133-4 Fonnum, 1975, A rapid radiochemical method for the determination of choline acetyltransferase, J Neurochem, 24, 407, 10.1111/j.1471-4159.1975.tb11895.x Grant, 1995, Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice, Genes Dev, 9, 1909, 10.1101/gad.9.15.1909 Grant, 1992, Impaired long-term potentiation, spatial learning, and hippocampal development in Fyn mutant mice, Science, 258, 1903, 10.1126/science.1361685 Greenberg, 1994, Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation, Proc Natl Acad Sci USA, 91, 7104, 10.1073/pnas.91.15.7104 Hansen, 1997, Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies, Neurology, 48, 126, 10.1212/WNL.48.1.126 Imahori, 1997, Physiology and pathology of tau protein kinases in relation to Alzheimer's disease, J Biochem (Tokyo), 121, 179 Kefalas, 1995, Signalling by the p60c-src family of protein-tyrosine kinases, Int J Biochem Cell Biol, 27, 551, 10.1016/1357-2725(95)00024-J Khachaturian, 1985, Diagnosis of Alzheimer's disease, Arch Neurol, 42, 1097, 10.1001/archneur.1985.04060100083029 Klein, 2002, ADDLs & protofibrils—the missing links?, Neurobiol Aging, 23, 231, 10.1016/S0197-4580(01)00312-8 Kobayashi, 1997, Activation of pp60c-Src depending on cell density in PC12h cells, J Biol Chem, 272, 16262, 10.1074/jbc.272.26.16262 Kojima, 1997, Rescuing impairment of long-term potentiation in Fyn-deficient mice by introducing Fyn transgene, Proc Natl Acad Sci USA, 94, 4761, 10.1073/pnas.94.9.4761 Lambert, 1998, Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins, Proc Natl Acad Sci USA, 95, 6448, 10.1073/pnas.95.11.6448 Lashuel, 2002, Neurodegenerative disease: amyloid pores from pathogenic mutations, Nature, 418, 291, 10.1038/418291a Lauri, 2000, High-frequency synaptic stimulation induces association of Fyn and c-Src to distinct phosphorylated components, NeuroReport, 11, 997, 10.1097/00001756-200004070-00020 Lee, 1998, Tau interacts with Src-family non-receptor tyrosine kinases, J Cell Sci, 111, 3167, 10.1242/jcs.111.21.3167 Lee, 2000, Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, 405, 360, 10.1038/35012636 Lesort, 1999, Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase, J Neurochem, 72, 576, 10.1046/j.1471-4159.1999.0720576.x Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem, 193265 Luciano, 2001, Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation, Oncogene, 20, 4935, 10.1038/sj.onc.1204661 Masliah, 1998, Mechanisms of synaptic pathology in Alzheimer's disease, J Neural Transm Suppl, 53147 McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Mirra, 1991, The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 Moore, 2002, A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid, J Biol Chem, 277, 47373, 10.1074/jbc.M208788200 Mucke, 2000, High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J Neurosci, 20, 4050, 10.1523/JNEUROSCI.20-11-04050.2000 Rapoport, 2000, PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons, J Neurochem, 74, 125, 10.1046/j.1471-4159.2000.0740125.x Resh, 1998, Fyn, a Src family tyrosine kinase, Int J Biochem Cell Biol, 30, 1159, 10.1016/S1357-2725(98)00089-2 Sala, 1999, The fyn art of N-methyl-D-aspartate receptor phosphorylation, Proc Natl Acad Sci USA, 96, 335, 10.1073/pnas.96.2.335 Samuel, 1996, Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease, J Neuropathol Exp Neurol, 55, 44, 10.1097/00005072-199601000-00005 Shirazi, 1993, The protein tyrosine kinase, fyn, in Alzheimer's disease pathology, NeuroReport, 4, 435, 10.1097/00001756-199304000-00024 Suzuki, 1995, NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain, Biochem Biophys Res Commun, 216, 582, 10.1006/bbrc.1995.2662 Terry, 1999, The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations, 187 Terry, 1991, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann Neurol, 30, 572, 10.1002/ana.410300410 Terry, 1981, Some morphometric aspects of the brain in senile dementia of the Alzheimer type, Ann Neurol, 10, 184, 10.1002/ana.410100209 Town, 2002, Mullan M. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro, J Neurosci Res, 69, 362, 10.1002/jnr.10299 van’t Hof, 1997, Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3, J Cell Biol, 136, 1023, 10.1083/jcb.136.5.1023 Williamson, 2002, Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases, J Neurosci, 22, 10, 10.1523/JNEUROSCI.22-01-00010.2002 Young, 2002, Changes in protein kinase C (PKC) activity, isozyme translocation, and GAP-43 phosphorylation in the rat hippocampal formation after a single-trial contextual fear conditioning paradigm, Hippocampus, 12, 457, 10.1002/hipo.10015 Zamora-Leon, 2001, Binding of Fyn to MAP-2c through an SH3 binding domain. Regulation of the interaction by ERK2, J Biol Chem, 276, 39950, 10.1074/jbc.M107807200 Zhang, 1996, A beta peptide enhances focal adhesion kinase/Fyn association in a rat CNS nerve cell line, Neurosci Lett, 211, 187, 10.1016/0304-3940(96)12761-0 Zheng, 2002, Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures, Neuroscience, 115, 201, 10.1016/S0306-4522(02)00404-9